Evercore ISI Group analyst Elizabeth Anderson initiates coverage on Quest Diagnostics (NYSE:DGX) with a In-Line rating and announces Price Target of $159.
RBC Capital Markets initiated coverage on Marinus Pharmaceuticals Inc (NASDAQ:MRNS) with an Outperform rating, Speculative Risk, and a price target of…